Probiotic characterization of Pediococcus strains isolated from Iranian cereal-dairy fermented product: Interaction with pathogenic bacteria and the enteric cell line Caco-2.
- 2020-11
- Journal of Bioscience and Bioengineering 130(5)
- A. Vasiee
- F. Falah
- B. A. Behbahani
- Farideh Tabatabaee-Yazdi
- PubMed: 32753308
- DOI: 10.1016/j.jbiosc.2020.07.002
Abstract
In present study, we investigated the probiotic potential of three Pediococcus spp. isolated from Iranian traditional fermented cereal-dairy product, Tarkhineh. These 3 strains were identified as Pediococcus acidilactici VKU2, P. acidilactici IAH-5 and P. pentosaceus DHR005 by 16S rRNA gene sequencing. All the strain were found tolerate to pH 3 and 0.3% oxall for 3 h as well as simulated gastric and intestinal juice. P. acidilactici IAH-5 showed the highest cholesterol removal (67.52%), hydroxyl radical scavenging activity (58.32%), hydrophobicity (40.3%) and auto-aggregation (48%). Pediococcus spp. inhibited the growth of tested pathogens (Escherichia coli ATCC 25922, Pseudomonas aeruginosa PTCC 1707, Salmonella typhimurium PTCC 1609, and Staphylococcus aureus ATCC 25923) which the most susceptible strain was S. aureus. In competition assay, P. acidilactici IAH-5 was able to inhibited adhesion of 67.3% of S. typhimurium and in inhibition assay 45.8% of the pathogenic adhesion to Caco-2 cells were decreased. P. acidilactici VKU2 and P. acidilactici IAH-5 showed 16.32 and 12.25% adhesion to simulated epithelial cell line which were also confirmed by scanning electron microscopy. Pediococcus spp. did not showed DNase production or hemolytic activity which confirm its safety aspects. Our findings suggested that the P. acidilactici IAH-5 has the best properties with probiotic features and cholesterol assimilation for its application as novel bio-therapeutic and bio-preservation agents.
Keywords: Antagonistic activity; Caco-2 cell line; Pediococcus; Probiotics; Serum cholesterol.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Pediococcus acidilactici | Improved Cholesterol Levels | Beneficial | Large |
Pediococcus acidilactici | Increased Antioxidant Activity | Beneficial | Moderate |
Pediococcus acidilactici | Reduced Pathogenic Adhesion to Intestinal Cells | Beneficial | Moderate |
Pediococcus acidilactici | Reduced Pathogenic Bacterial Growth | Beneficial | Large |
Pediococcus acidilactici KABP™-021 | Improved Gastric Tolerance | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Improved Oxalic Acid Tolerance | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Increased Antioxidant Activity | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Increased Cell Adhesion | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Reduced Pathogen Adhesion to Cells | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Reduced Pathogen Growth | Beneficial | Large |
Pediococcus acidilactici KABP™-021 | Reduced Total Cholesterol Levels | Beneficial | Large |